Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-Based Strategies Against SARS-CoV-2 Attack: An Updated In Silico Perspective
Gautier Moroy, Pierre Tuffèry
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 11

Showing 11 citing articles:

Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
Robert Konkel, Aleksandra Milewska, Thuc Nguyen Dan, et al.
Antiviral Research (2023) Vol. 219, pp. 105731-105731
Open Access | Times Cited: 10
Computational design of anti-cancer peptides tailored to target specific tumor markers
Aisha Naeem, Nighat Noureen, Shaikha Khalid Al-Naemi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
Michela Murdocca, Isabella Romeo, Gennaro Citro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 891-891
Open Access | Times Cited: 1
Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design
S. Anusuya, V. Anbazhagan, M. Michael Gromiha
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 29, pp. 2396-2409
Closed Access | Times Cited: 8
Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational approaches
Aisha A. Alsfouk, Abdelmoujoud Faris, Ivana Cacciatore, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Recombinant antibody fragment therapeutics: Current status and future prospects of scFv, nanobody, and mimotopes
Hajarossadat Ghaderi, Atefeh Alipour, Arya Mohammadi Zadeh Holagh, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105009-105009
Closed Access | Times Cited: 3
Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2
Norbert Odolczyk, Joanna Klim, Malgorzata Bialoskorska, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization
Maria G. Byazrova, Pia Gattinger, Ekaterina A. Astakhova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5104-5104
Open Access | Times Cited: 2
A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors
Anand Chopra, Ali H. Shukri, Hemanta Adhikary, et al.
Peptides (2022) Vol. 158, pp. 170898-170898
Open Access | Times Cited: 4
T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access
Főbb trendek a szintetikus peptidekkel folytatott kutatási témákban • Main Trends in Research Topics with Synthetic Peptides
Gábor Mezó, Szilvia Bősze
Magyar Tudomány (2023)
Open Access
Page 1

Scroll to top